ProQR Therapeutics N.V. (PRQR) stock
PRQRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.03 (-2.54%)
Close on Nov 17, 2026Market cap $121.17MP/E –Yield –
ProQR Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ProQR Therapeutics's enterprise value was $9.15M on Nov 11, 2026, against $124.60M a year earlier. Over the last 5 years it ranged from -$107.29M to $315.83M, with a median of $49.61M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.15M | -89.8% |
| 2025 | Dec 31, 2025 | $89.98M | -29.8% |
| 2024 | Dec 31, 2024 | $128.19M | +349.7% |
| 2023 | Dec 29, 2023 | $28.50M | -82.5% |
| 2022 | Dec 30, 2022 | $163.21M | -48.3% |
| 2021 | Dec 31, 2021 | $315.83M | +164.4% |
| 2020 | Dec 31, 2020 | $119.44M | -66.4% |
| 2019 | Dec 31, 2019 | $355.23M | -34.9% |
| 2018 | Dec 31, 2018 | $546.05M | +4876.6% |
| 2017 | Dec 29, 2017 | $10.97M | -23.2% |
| 2016 | Dec 30, 2016 | $14.28M | – |
See a number that looks wrong?